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Editorials
Commission on Macroeconomics and Health
Richard G.A. Feachem1
Between 1984 and 1987, Dr Gro
Harlem Brundtland, the then Prime
Minister of Norway, chaired the World
Commission on Environment and
Development, also known as the
Brundtland Commission. The work
of this Commission, and of the UN
Conference on Environment and
Development, held in Rio de Janeiro
in 1992, moved environmental concerns
to centre stage in debates concerning
macroeconomic policy and develop-
ment. On becoming Director-General
of WHO in 1998, Dr Brundtland was
inspired to do for health what she
had previously helped to achieve for
the environment, and in January 2000
set up the Commission on Macro-
economics and Health. It had a two-year
mandate to debate, research, and reach
conclusions about the role of health
in economic development. Its report,
published on 20 December 2001, has
received much attention in the media
and is now being widely circulated (1).
The Commission consisted of
eighteen commissioners,a four of
whom, including myself, came from
the health sector and were relatively
unimportant — unimportant, because
our views on the importance of health
and its close relationship to economic
well-being and stability are already well
known. We are seen as ‘‘special plea-
ders’’ for greater investment in health.
The excitement and the power of the
Commission derives instead from the
other fourteen Commissioners —
individuals who are prominent in eco-
nomics, finance, development, trade,
and political leadership. Their views on
the essential links between health in-
vestment and economic growth cannot
therefore be discarded lightly. They
have immense experience in economic
planning and prioritization in low-
income, middle-income, and wealthy
countries. They are well aware of the
difficult trade-offs and choices that
ministers of finance must make.
Nevertheless, they have reached striking
conclusions about the central position
of health in economic development and
the need for far greater investments in
human health if countries are to enjoy
sustainable development and steady
improvements in human welfare.
I recommend the full report of the
Commission to all readers of the Bulletin.
This special issue of the Bulletin taps
into the mine of supportive work
carried out on behalf of the Commission
by the six Working Groups that it
established. Published in this issue are
shortened versions of ten of the working
papers commissioned by the Working
Groups, together with a round table
discussion on the work of the Commis-
sion, and an interview with the Com-
mission Chair, Professor Jeffrey Sachs.
We hope that the richness and the
diversity of this material will be stimu-
lating and useful to Bulletin readers.
We are also very pleased to publish
in this issue a guest editorial by Dr Julio
Frenk and Dr Felicia Knaul. Dr Frenk
is the Minister of Health of Mexico.
He was previously a senior official at
WHO and it was his vision, alongside
that of Dr Brundtland, that launched the
Commission on Macroeconomics and
Health. We are delighted that he is now
able to comment on the work of the
Commission from the perspective of
his leadership of the health sector in an
influential and reformist middle-income
country.
Two coincidences make the find-
ings of the Commission especially
relevant and timely. First, this month
marks the launch of the new Global
Fund to Fight AIDS, Tuberculosis, and
Malaria. The thinking behind this Fund,
which has flowed from the leadership
and advocacy of UN Secretary-General
Kofi Annan and the deliberations of
the last several G8 Summits, is precisely
the need to greatly increase effective
investment in health in poorer countries.
The work of the Commission provides
much supporting evidence and guidance
that will assist the early years of the
work of the new Global Fund.
Second, the events of 11 September
last year have reminded us of the
linkage between global security and
global health. As the Economist pointed
out in an editorial on 22December 2001,
‘‘there is a correlation between sickness
and political instability’’. We must hope
that this wisdom is heeded in the
capital cities of wealthy countries. Win-
ning peace is far more difficult than
winning wars and requires massive and
sustained assistance for poor countries
to improve the health and education
status of their populations, and particu-
larly of girls and women. n
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